Form 4: Aethlon Medical Director Sells Shares to Cover Tax Obligations

Director Nicolas Gikakis sold 5,244 shares of Aethlon Medical Inc. to cover tax obligations related to the vesting of restricted stock units.

Summary

• On June 28, 2024, Nicolas Gikakis, a director of Aethlon Medical Inc., disposed of 5,244 shares of common stock.
• The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs) granted on April 16, 2024.
• The shares were sold at a price of $0.499 per share.
• Following the transaction, Gikakis directly owns 41,330 shares of Aethlon Medical Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a routine transaction (tax obligation). It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Sales to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on other stakeholders.

Key Dates

Keywords

Aethlon Medical, AEMD, Nicolas Gikakis, Form 4, Director, Share Sale, Tax Withholding, RSU, Beneficial Ownership